Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
- ILa | -.--% | +1,39 % | +107,88 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 01/10/10 |
Moshe Dori
DFI | Director of Finance/CFO | - | 29/01/19 |
Eitan Blank
COO | Chief Operating Officer | 54 | 01/01/07 |
Ofer Schlesinger
CTO | Chief Tech/Sci/R&D Officer | 59 | 23/07/14 |
Ilan Ben Oren
CTO | Chief Tech/Sci/R&D Officer | 59 | 11/04/06 |
Didier Samuel
PRN | Corporate Officer/Principal | - | - |
Ari Soae
PRN | Corporate Officer/Principal | 46 | 01/01/06 |
Ilan Haikin
AUD | Comptroller/Controller/Auditor | 69 | 21/11/10 |
Gavin Doree
SAM | Sales & Marketing | 47 | 29/07/13 |
Susan Alpert
LAW | General Counsel | 78 | 01/01/11 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 04/07/16 |
Moshe Arkin
BRD | Director/Board Member | 69 | 01/01/06 |
Hanna Lerman
BRD | Director/Board Member | 51 | 16/04/15 |
Itai Arkin
BRD | Director/Board Member | 35 | 16/04/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 26 917 095 | 6 557 013 ( 24,36 %) | 0 | 24,36 % |
Información de la empresa
Meridian Bioscience Israel Ltd.
4 Ha'maayan Street
7177872, Modi'in-Maccabim-Re'ut
+
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+107,88 % | 45,97 M | |
-3,79 % | 184 mil M | |
-0,84 % | 108 mil M | |
-3,75 % | 67,8 mil M | |
+3,45 % | 51,05 mil M | |
+9,04 % | 44,67 mil M | |
+3,40 % | 41,78 mil M | |
+3,66 % | 26,59 mil M | |
+3,21 % | 26,78 mil M | |
+15,23 % | 25,86 mil M |
- Bolsa de valores
- Acciones
- Acción EXEN
- Empresa Exalenz Bioscience Ltd